Posted 30th December 2016 by Jane Williams
Tiffany Scharschmidt spoke to us about her thoughts on the skin microbiome, immune responses and inflammatory skin diseases.
Posted 21st December 2016 by Jane Williams
At the 3rd Microbiome R&D and Business Collaboration Forum: Europe, topics covered the impact of microbiomes on human health and disease, developing therapeutics, and investment into the microbiome. Duc H. Le, the UK Editor-in-Chief of EBioMedicine, summarises some of the presentations that took place.
Posted 5th December 2016 by Jane Williams
As a start-up looking for funding, every venture capital firm might seem the same, but all money is not created equal. When you present yourself to a venture capitalist, you’re selling to a business. This means you need to get to know their business and what motivates their decision-makers.
Posted 25th November 2016 by Jane Williams
Artificial digestive systems are increasingly used as a relevant alternative to in vivo studies for ethical, technical, regulatory and cost reasons. For more than 20 years, CIDAM, from the University of Auvergne in France, has been developing platforms such as the artificial digestion associating dissolution apparatus, mastication simulator, gastric and small intestinal models, large intestinal systems and intestinal cells in culture.
Posted 14th November 2016 by Jane Williams
The vast amount of research into the human microbiome is attracting new companies to the field and the race to translate scientific data into viable products has begun. Financial interest in the microbiome is at an all-time high, giving many scientists the opportunity to start their own business as product development or service companies.
Posted 4th November 2016 by Jane Williams
The human gut is home to trillions of microorganisms (gut microbiota) that make up a complex ecological community with many more bacterial cells than the total number of human cells. Most of the bacteria in the gut are harmless or beneficial and protect against pathogens, extract nutrients and energy from our diet, and contribute to immune regulatory functions. 
Posted 24th October 2016 by Jane Williams
Obesity affects 600 million people globally, but the range of available treatments is limited. Recent findings that demonstrate a relationship between the gut microbiome and obesity have brought new hope that bacteria-based therapeutics might offer novel treatments.
Posted 5th October 2016 by Jane Williams
Whilst completing my industrial PhD in Biotechnology, I focused on the characterisation of microbial communities of dairy products, using Next Generation Sequencing approaches in order to evaluate the quality of cheeses. The shift towards studying the human gut microbiome was quite easy. Unfortunately, at the beginning we found that we couldn’t evaluate the “quality” of the gut flora as it was a relatively under-explored field.